Corvidane
Corvidane is developing Corvida™ to treat TWO formidable diseases. Corvidane uses a novel approach to treat metabolic and inflammatory diseases. Corvida(TM) for Atherosclerosis - In development to be a Best-in-Class, orally administered adjunct to lipid regulating therapies (Statins/PCSK9) that targets atherosclerotic plaques, the major factor in Heart Attacks and Stroke. Corvida(TM) for MASH - In development to be a Best-in-Class, orally administered drug to treat MASH, which is the leading cause of liver transplants in the United States.
7-day free trial · no credit card
Verified contacts
2
available on Kipplo
LinkedIn employees
3
1 to 10 range
Open roles
—
no listings
Distinct roles
2
indexed titles
Tech stack
2
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 2 verified contacts at Corvidane
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
2 contacts with verified email or phone · masked until revealed.
No verified contacts on record for this company yet.
Top roles at Corvidane
2 distinct titles indexed · top 2 shown.
- 1nbm
- 1vp cmc chemistry manufacturing and controls
Sign up to unlock all 2 contacts at Corvidane
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 2 verified contacts at Corvidane
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.